著者: ChesnutC H, McClungM R, EnsrudK E, BellN H, GenantH K, HarrisS T, SingerF R, StockJ L, YoodR A, DelmasP D

原題: Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling.

著者: RossiniM, GattiD, ZamberlanN, BragaV, DorizziR, AdamiS

原題: Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis.

著者: BuffoL, RossiniM, BuoncristianoA, GirardelloS, ZamberlanN, DianiF, AdamiS

原題: [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate].

著者: BoneH G, DownsR W, TucciJ R, HarrisS T, WeinsteinR S, LicataA A, McClungM R, KimmelD B, GertzB J, HaleE, PolvinoW J

原題: Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers.

著者: ChavassieuxP M, ArlotM E, RedaC, WeiL, YatesA J, MeunierP J

原題: Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.

著者: StockJ L, BellN H, ChesnutC H, EnsrudK E, GenantH K, HarrisS T, McClungM R, SingerF R, YoodR A, Pryor-TillotsonS, WeiL, SantoraA C

原題: Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women.

著者: RavnP, WeissS R, Rodriguez-PortalesJ A, McClungM R, WasnichR D, GilchristN L, SambrookP, FogelmanI, KrupaD, YatesA J, DaifotisA, FuleihanG E

原題: Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group.

著者: ChavassieuxP M, ArlotM E, RouxJ P, PorteroN, DaifotisA, YatesA J, HamdyN A, MaliceM P, FreedholmD, MeunierP J

原題: Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies.

著者: RossiniM, GattiD, GirardelloS, BragaV, JamesG, AdamiS

原題: Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis.

著者: SosaM, HernándezD, SegarraM C, GómezA, de la PeñaE, BetancorP

原題: Effect of two forms of alendronate administration upon bone mass after two years of treatment.

著者: MeunierP J, ArlotM, ChavassieuxP, YatesA J

原題: The effects of alendronate on bone turnover and bone quality.

著者: BaggerYu Z, TankóLászló B, AlexandersenPeter, RavnPernille, ChristiansenClaus

原題: Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

著者: PalombaStefano, OrioFrancesco, RussoTiziana, ColaoAnnamaria, LombardiGaetano, ZulloFulvio

原題: Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy.

著者: SambrookP N, GeusensP, RibotC, SolimanoJ A, Ferrer-BarriendosJ, GainesK, VerbruggenN, MeltonM E

原題: Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International.

著者: EnsrudKristine E, Barrett-ConnorElizabeth L, SchwartzAnn, SantoraArthur C, BauerDouglas C, SuryawanshiShailaja, FeldsteinAdrianne, HaskellWilliam L, HochbergMarc C, TornerJames C, LombardiAntonio, BlackDennis M,

原題: Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.